Technion-led study finds early changes in tumors’ immune environment may predict treatment success better than their initial ...

Cancer immunotherapy, particularly immune checkpoint inhibitors (ICIs), has emerged as a pillar of modern oncology. However, clinical response rates in head and neck squamous cell carcinoma (HNSCC) ...

Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or ...

Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the ...

After the mice received the combination of five cytokine mRNAs and three tumor antigen mRNAs, the researchers observed less fibrotic material around the tumors and increased tumor cell necrosis. These ...

Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.

Oral vaccines hold great promise for colorectal cancer (CRC) immunotherapy but are limited by inefficient mucosal delivery and a lack of spatiotemporal control over immune activation. Here we report a ...

Treatment with immune checkpoint inhibitors can significantly increase risk for major adverse cardiovascular events among patients with cancer, including heart failure, myocardial infarction and ...

Between Immunotherapy and Daily Life When we hear the term "immunotherapy," it is easy to conjure up heavy images of cancer treatment or specialized hospitals. At the same time, our daily lives are ...

Tuberculosis (TB) remains one of the world's leading causes of death, and preventing post-treatment relapse continues to be a ...

The ‘Real Housewives of Beverly Hills’ alum shared the health reminder amid a frank look at the struggles of ongoing ...